8Beta-substituted 11beta-aryl-estra-1,3,5,(10)-triene derivatives
AssigneeSchering Corporation
InventorsNico Brauer, Olaf Peters, Alexander Hillisch, Christa Hegele-Hartung, Peter Muhn
Life of this patent
Estimating the term…
Abstract
This invention relates to 11β-(para-substituted)phenyl-estra-1,3,5(10)-trienes with a straight-chin or branched-chain, optionally partially or completely halogenated alkyl radical or alkenyl radical in each case with up to 5 carbon atoms, an ethinyl radical or prop-1-inyl radical in 8β-position. The new compounds can be used for contraception in men and women, without influencing other estrogen-sensitive organs, such as the uterus or the liver. They are also suitable for the treatment of benign or malignant proliferative diseases of the ovary, such as ovarian cancer and granulosa cell tumors.
Claims24
Compounds of general formula I
- 12
- in which
- R2 means hydrogen, halogen (F, Cl, Br, I);
- a radical R18 or R18O, whereby R18 means hydrogen, an alkyl radical or alkanoyl radical (straight-chain or branched-chain, saturated or unsaturated with up to 6 carbon atoms and up to 2 multiple bonds), a benzoyl radical, a trifluoromethyl group;
- a radical R19SO2O, in which R19 means an R20R21N group, in which R20 and R21, independently of one another, mean a hydrogen, a C1-C5-alkyl radical, a group C(O)R22, in which R22 means a hydrocarbon radical (optionally substituted, straight-chain or branched-chain, saturated or unsaturated in up to three places, partially or completely halogenated) with up to 10 carbon atoms), an optionally substituted C3-C7-cycloalkyl radical, an optionally substituted C4-C15-cycloalkylalkyl radical or an optionally substituted aryl, heteroaryl or aralkyl radical, or, together with the N-atom, means a polymethylenimino radical with 4 to 6 C atoms or a morpholino radical;
- R3 means a radical R18O, R19SO2O or OC(O)R22, with R18, R19 and R22 in the meaning that is indicated under R2, and in addition R18 means an aryl, hetaryl or aralkyl radical;
- R6,R7 mean hydrogen;
- R6′ means hydrogen, a hydroxy group, a group R22 in the meaning that is indicated under R2;
- R7′ means hydrogen, halogen, a group R18O, R19SO2O, OC(O)R22, with R18, R19, and R22 in the meaning that is indicated under R2;
- R8 means an alkyl radical or alkenyl radical (both straight-chain or branched-chain, optionally partially or completely halogenated, with up to 5 carbon atoms), an ethinyl or prop-1-inyl radical;
- X means a direct bond, an oxygen or sulfur atom,
- n means an integer from 1 to 12, whereby the corresponding alkylene group can be interrupted by up to 3 O, S or N-methyl,
- Y means an amine —NR25R26, with R25 and R26 of the same or a different type, hydrogen, a hydrocarbon radical (optionally substituted, straight-chain or branched-chain, saturated or unsaturated in up to three places, optionally partially or completely halogenated) with up to 10 carbon atoms, an optionally substituted C3-C7-cycloalkyl radical, an optionally substituted C4-C15-cycloalkylalkyl radical or an optionally substituted aryl, heteroaryl or aralkyl radical or together with the nitrogen a heterocyclic compound (optionally with another heteoratom (O, S, N) that is optionally substituted with a C1-C4-alkyl radical),
- an amide CO—NR25R26 with R25, R26 of the same or a different type, hydrogen, a hydrocarbon radical (optionally substituted, straight-chain or branched-chain, saturated or unsaturated in up to three places, optionally partially or completely halogenated) with up to 10 carbon atoms, an optionally substituted C3-C7-cycloalkyl radical, an optionally substituted C4-C15-cycloalkylalkyl radical or an optionally substituted aryl, heteroaryl or aralkyl radical or together with the nitrogen a heterocyclic compound (optionally with another heteroatom (O, S, N), optionally substituted with a C1-C4-alkyl radical),
- a grouping —S(O)mR27 with m=0, 1 or 2, and R27 as a hydrocarbon radical (optionally substituted, straight-chain or branched-chain, saturated or unsaturated in up to three places, optionally partially or completely halogenated) with up to 10 carbon atoms, an optionally substituted C3-C7-cycloalkyl radical;
- an optionally substituted C4-C15-cycloalkylalkyl radical or an optionally substituted aryl, heteroaryl or aralkyl radical;
- R14 means hydrogen, an additional bond with R16;
- R15 means hydrogen, an additional bond with R14, R6;
- R16 means hydrogen, a bond with R15;
- R15′,R16′, independently of one another, mean hydrogen, halogen, a group R18O, R19SO2O or OC(O)R22, with R18, R19 and R22 in each case in the meaning that is indicated under R2;
- R17, R17′ each mean a hydrogen atom;
- a hydrogen atom and a halogen atom;
- a hydrogen atom and a benzyloxy group;
- a hydrogen atom and a group R19SO2—O—;
- a group R18 and a group —C(O)R22 or —O—C(O)R22;
- a group R18 —O— and a group R18—;
- a group R18 —O— and a group —O—C(O)R22, in each case with R18, R19 and R22 in the meaning that is indicated under R2;
- R17, R17′ together mean a group ═CR23R24, in which R23 and R24, independently of one another, represent a hydrogen atom and a halogen atom, or together represent an oxygen atom, as well as their pharmacologically compatible salts with acids in the case of the presence of a basic nitrogen atom in the compound of general formula I.
Use of the structural portion of 11β-(para-substituted)phenyl-estra-1,3,5(10)-triene with a straight-chain or branched-chain, optionally partially or completely halogenated alkyl radical or alkenyl radical in each case with up to 5 carbon atoms, an ethinyl radical or prop-1-inyl radical in 8β-position as a component of the entire structure of the compounds that have a contraceptive effect on men and women without influencing other estrogen-sensitive organs such as the uterus or the liver.
Use of the structural portion of the 11β-(para-substituted)phenyl-estra-1,3,5(10)-triene with a straight-chain or branched-chain, optionally partially or completely halogenated alkyl radical or alkenyl radical in each case with up to 5 carbon atoms, an ethinyl or prop-1-inyl radical in 8β-position as a component of the entire structure of compounds that are suitable for treating benign or malignant proliferative diseases of the ovary, such as ovarian cancer and granulosa cell tumors.
Dependencies are inferred from the claim text.